• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Early MRD predicts disease recurrence and benefit from adjuvant chemotherapy in CRC.

作者信息

Killock David

机构信息

Nature Reviews Clinical Oncology, .

出版信息

Nat Rev Clin Oncol. 2023 Mar;20(3):137. doi: 10.1038/s41571-023-00737-2.

DOI:10.1038/s41571-023-00737-2
PMID:36717746
Abstract
摘要

相似文献

1
Early MRD predicts disease recurrence and benefit from adjuvant chemotherapy in CRC.早期微小残留病可预测结直肠癌的疾病复发及辅助化疗的获益情况。
Nat Rev Clin Oncol. 2023 Mar;20(3):137. doi: 10.1038/s41571-023-00737-2.
2
Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer.结直肠癌肺转移根治性切除术后辅助化疗的益处
Ann Surg Oncol. 2016 Mar;23(3):928-35. doi: 10.1245/s10434-015-4951-z. Epub 2015 Oct 29.
3
Surgical debulking before or after chemotherapy: stemming the tide on ovarian cancer recurrence.化疗前或化疗后的手术减瘤：遏制卵巢癌复发趋势
Onkologie. 2010;33(6):286-7. doi: 10.1159/000314637. Epub 2010 May 14.
4
Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.基于组合癌症特征的基因签名集的鉴定和构建，以预测 II 期结直肠癌的复发和化疗获益。
JAMA Oncol. 2016 Jan;2(1):37-45. doi: 10.1001/jamaoncol.2015.3413.
5
Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy.流式细胞术评估新诊断的 T 细胞急性淋巴细胞白血病中 CD38 的表达水平及其在可测量残留疾病、难治性疾病和复发性疾病中对化疗的表达的影响：对抗 CD38 免疫治疗的意义。
J Immunother Cancer. 2020 May;8(1). doi: 10.1136/jitc-2020-000630.
6
Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study.口服替加氟/尿嘧啶联合PSK辅助免疫化疗用于II期或III期结直肠癌患者：一项随机对照研究。
Br J Cancer. 2004 Mar 8;90(5):1003-10. doi: 10.1038/sj.bjc.6601619.
7
The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer.化疗相关中性粒细胞/淋巴细胞计数对结直肠癌辅助化疗预后的影响。
BMC Cancer. 2013 Apr 3;13:177. doi: 10.1186/1471-2407-13-177.
8
Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment.监测高危复发性急性淋巴细胞白血病患儿的微小残留病：早期和晚期评估的预后相关性。
Leukemia. 2015 Aug;29(8):1648-55. doi: 10.1038/leu.2015.59. Epub 2015 Mar 9.
9
LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.LGR5和CD133作为结直肠癌氟尿嘧啶类辅助化疗的预后和预测标志物。
Acta Oncol. 2016 Dec;55(12):1425-1433. doi: 10.1080/0284186X.2016.1201215. Epub 2016 Jul 20.
10
Efficacy and tolerability of adjuvant oral capecitabine plus intravenous oxaliplatin (XELOX) in Asian patients with colorectal cancer: 4-year analysis.亚洲结直肠癌患者辅助口服卡培他滨联合静脉注射奥沙利铂（XELOX方案）的疗效及耐受性：4年分析
Asian Pac J Cancer Prev. 2014 Jan;14(11):6585-90. doi: 10.7314/apjcp.2013.14.11.6585.

引用本文的文献

1
Antitumor Activity of Polysaccharides Through Mitochondrial Apoptosis in Cellular and Zebrafish Models.多糖在细胞和斑马鱼模型中通过线粒体凋亡发挥的抗肿瘤活性
Mar Drugs. 2025 Jul 29;23(8):304. doi: 10.3390/md23080304.
2
Multimodal cell-free DNA whole-genome TAPS is sensitive and reveals specific cancer signals.多模态游离DNA全基因组TAPS检测灵敏且能揭示特定癌症信号。
Nat Commun. 2025 Jan 8;16(1):430. doi: 10.1038/s41467-024-55428-y.
3
A log odds of positive lymph nodes-based predictive model effectively forecasts prognosis and guides postoperative adjuvant chemotherapy duration in stage III colon cancer: a multi-center retrospective cohort study.

本文引用的文献

1
Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer.结直肠癌患者的分子残留疾病与辅助化疗疗效。
Nat Med. 2023 Jan;29(1):127-134. doi: 10.1038/s41591-022-02115-4. Epub 2023 Jan 16.
基于对数优势阳性淋巴结的预测模型能有效预测 III 期结肠癌的预后，并指导术后辅助化疗时间：一项多中心回顾性队列研究。
BMC Cancer. 2024 Sep 2;24(1):1088. doi: 10.1186/s12885-024-12875-6.
4
STING-targeted PET imaging: unveiling tumor immunogenicity post-chemotherapy in colorectal cancer.靶向STING的PET成像：揭示结直肠癌化疗后的肿瘤免疫原性
Eur J Nucl Med Mol Imaging. 2024 Jul;51(9):2758-2760. doi: 10.1007/s00259-024-06769-9.
5
Spatial Effects of Infiltrating T cells on Neighbouring Cancer Cells and Prognosis in Stage III CRC patients.III期结直肠癌患者中浸润性T细胞对邻近癌细胞的空间效应及预后
bioRxiv. 2024 Mar 28:2024.01.30.577720. doi: 10.1101/2024.01.30.577720.
6
A competing risk nomogram to predict cancer-specific mortality of patients with late-onset colorectal cancer.用于预测晚期结直肠癌患者癌症特异性死亡率的竞争风险列线图。
J Cancer Res Clin Oncol. 2023 Nov;149(15):14025-14033. doi: 10.1007/s00432-023-05069-3. Epub 2023 Aug 7.